Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Julius N. Meissner"'
Autor:
Niklas M. Beckonert, Felix J. Bode, Franziska Dorn, Sebastian Stösser, Julius N. Meißner, Julia Nordsiek, Christine Kindler, Taraneh Ebrahimi, Christoph Riegler, Christian H. Nolte, Gabor C. Petzold, Johannes M. Weller
Publikováno v:
Stroke: Vascular and Interventional Neurology, Vol 3, Iss 5 (2023)
Background COVID‐19 is associated with an increased stroke risk. Moreover, outcome at discharge was worse in patients with large‐vessel occlusion stroke with concomitant COVID‐19 receiving endovascular treatment (ET). We aimed to investigate th
Externí odkaz:
https://doaj.org/article/59ddcd90637d47dba3d0ad172a6c7661
Autor:
Johannes M. Weller, Franziska Dorn, Julius N. Meissner, Sebastian Stösser, Niklas M. Beckonert, Julia Nordsiek, Christine Kindler, Christoph Riegler, Fee Keil, Gabor C. Petzold, Felix J. Bode, the GSR-ET investigators
Publikováno v:
Neurological Research and Practice, Vol 4, Iss 1, Pp 1-7 (2022)
Abstract Background Oral anticoagulation (OAC) is the mainstay of secondary prevention in ischemic stroke patients with atrial fibrillation (AF). However, in AF patients with large vessel occlusion stroke treated by endovascular therapy (ET) and acut
Externí odkaz:
https://doaj.org/article/ecd792dd177741a4b130fed04603d96a
Autor:
Jose S. Lopez-Noguerola, Nicolai M. E. Giessen, Maximilian Ueberück, Julius N. Meißner, Charlotte E. Pelgrim, Johnathan Adams, Oliver Wirths, Yvonne Bouter, Thomas A. Bayer
Publikováno v:
Frontiers in Aging Neuroscience, Vol 10 (2018)
The N-terminally truncated pyroglutamate Aβ3−42 (AβpE3−42) and Aβ4−42 peptides are known to be highly abundant in the brain of Alzheimer's disease (AD) patients. Both peptides show enhanced aggregation and neurotoxicity in comparison to full
Externí odkaz:
https://doaj.org/article/28d8f679fcd64dd8bc87e84d7f93e1c3
Autor:
Johannes M Weller, Franziska Dorn, Julius N Meissner, Sebastian Stösser, Niklas M Beckonert, Julia Nordsiek, Christine Kindler, Milani Deb-Chatterji, Gabor C Petzold, Felix J Bode, A. Reich, O. Nikoubashman, J. Röther, B. Eckert, M. Braun, G.F. Hamann, E. Siebert, C.H. Nolte, G. Bohner, R.M. Eckert, J. Borggrefe, P. Schellinger, J. Berrouschot, A. Bormann, C. Kraemer, H. Leischner, M. Petersen, F. Stögbauer, T. Boeck-Behrens, S. Wunderlich, A. Ludolph, K.H. Henn, C. Gerloff, J. Fiehler, G. Thomalla, A. Alegiani, J.H. Schäfer, F. Keil, S. Tiedt, L. Kellert, C. Trumm, U. Ernemann, S. Poli, J. Liman, M. Ernst, K. Gröschel, T. Uphaus
Publikováno v:
International Journal of Stroke. 18:453-461
Background: Endovascular treatment (ET) is standard of care in patients with acute ischemic stroke due to large vessel occlusion, but data on ET in young patients remain limited. Aim: We aim to compare outcomes for young stroke patients undergoing ET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b03a31054db51e94697ad9de96da0ed
https://doi.org/10.1177/17474930221119602
https://doi.org/10.1177/17474930221119602
Publikováno v:
Der Nervenarzt.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b124b43e67f2846306dbb04f2b1749a1
https://doi.org/10.1007/s00115-023-01443-1
https://doi.org/10.1007/s00115-023-01443-1
Autor:
Sebastian, Stösser, Felix J, Bode, Julius N, Meissner, Johannes M, Weller, Christine, Kindler, Malte, Sauer, Daniel, Paech, Christoph, Riegler, Christian H, Nolte, Amitis, Pourian, Joachim, Röther, Nadja, Selo, Ulrike, Ernemann, Sven, Poli, Rosa Marie, Eckert, Georg, Bohner, Korbinian, Scherling, Franziska, Dorn, Gabor C, Petzold
Publikováno v:
Clinical neuroradiology.
Endovascular treatment (ET) in patients with large vessel occlusion stroke (LVOS) with unknown onset or an extended time window can be safe and effective if patients are selected by defined clinical and imaging criteria; however, it is unclear if the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::583e636539fe1045c6b82b2184bbc121
https://pubmed.ncbi.nlm.nih.gov/35796854
https://pubmed.ncbi.nlm.nih.gov/35796854
Publikováno v:
Journal of Alzheimer's Disease. 45:471-482
Pyroglutamate-modified amyloid-β (Aβ) at amino acid position three (Aβ(pE3-42)) is gaining considerable attention as a potential key player in the pathogenesis of Alzheimer's disease (AD). Aβ(pE3-42) is abundant in AD brain and has a high aggrega
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c381530e652f99c851737e901e59dd
https://doi.org/10.3233/jad-142868
https://doi.org/10.3233/jad-142868
Publikováno v:
Alzheimer's & Dementia. 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b5adc9f4a33bd1d9bb1674cc4e710e6
https://doi.org/10.1016/j.jalz.2017.07.553
https://doi.org/10.1016/j.jalz.2017.07.553